Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2013-002165-19-NL
EUCTR2013-002165-19-NL
Active, not recruiting
Not Applicable

Hypernatraemia and diuretics

Medical Center Leeuwarden0 sitesJuly 25, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsIntensive Care admissionsodium level in plasma > 142 mmol/LTherapeutic area: Body processes [G] - Circulatory and Respiratory Physiological Phenomena [G09]
DrugsCaptopril / hydrochloorthiazide

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intensive Care admissionsodium level in plasma > 142 mmol/L
Sponsor
Medical Center Leeuwarden
Status
Active, not recruiting
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 25, 2013
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Medical Center Leeuwarden

Eligibility Criteria

Inclusion Criteria

  • •admission in the intensive care
  • •age \> 18 years
  • •sodium level in plasma \> 142 mmol/L
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 20
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 30

Exclusion Criteria

  • •sodium level \> 142 mmol/L before admission
  • •no informed consent
  • •diabetes insipidus

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Hydrochloorthiazide and HypernatriaemieHypernatraemia
NCT01974739Medical Centre Leeuwarden50
Active, not recruiting
Phase 1
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluatio
EUCTR2006-002567-62-SKCardiokine Biopharma, LLC650
Active, not recruiting
Not Applicable
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient EvaluatioHyponatremiaMedDRA version: 9.1Level: LLTClassification code 10021038Term: Hyponatremia
EUCTR2006-002567-62-CZCardiokine Biopharma, LLC650
Active, not recruiting
Not Applicable
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient EvaluationEstudio BALANCE: Tratamiento de la Hyponatremia mediante lixivaptan en la evaluación del paciente con insuficiencia cardiaca con Clase III/IV de la NYHAHyponatremiaHiponatremiaMedDRA version: 9.1Level: LLTClassification code 10021038Term: Hyponatremia
EUCTR2006-002567-62-ESCardiokine Biopharma, LLC650
Active, not recruiting
Not Applicable
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient EvaluatioHyponatremiaMedDRA version: 9.1Level: LLTClassification code 10021038Term: Hyponatremia
EUCTR2006-002567-62-DECardiokine Biopharma, LLC650